Recce Pharmaceuticals to begin Phase 3 trials in Indonesia for diabetic foot infection treatment

Recce Pharmaceuticals to begin Phase 3 trials in Indonesia for diabetic foot infection treatment

Recce Pharmaceuticals Limited has received ethics approval from Indonesia’s Human Research Ethics Committee to initiate Phase 3 clinical trials of its topical gel, RECCE® 327 (R327G), designed for diabetic foot infections (DFIs). This green light enables the Australian-based company to move forward with its large-scale study in Indonesia, a country with one of the world’s […]

Orthocell secures key regulatory approval for Remplir in Singapore, paving way for ASEAN expansion

Orthocell secures key regulatory approval for Remplir in Singapore, paving way for ASEAN expansion

Orthocell, an Australian regenerative medicine company, has achieved a significant milestone with the receipt of major international regulatory approval for its nerve repair product Remplir from Singapore’s Health Sciences Authority (HSA). This regulatory clearance authorizes Orthocell to initiate sales in Singapore, marking the first international regulatory authorization for Remplir outside of Australia and New Zealand, […]

KT Corporation and Microsoft partner in multibillion-dollar initiative to propel AI innovation in Korea

KT Corporation and Microsoft partner in multibillion-dollar initiative to propel AI innovation in Korea

KT Corporation and Microsoft have embarked on a transformative five-year, multibillion-dollar strategic partnership aimed at catalyzing AI-driven innovation throughout Korea. This ambitious collaboration seeks to facilitate the deployment of advanced AI technologies across over 650,000 businesses and 17 million consumers, fostering the integration of AI-enabled services in both the public and private sectors. Central to […]